We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/5/2019 14:28 | lol, Upomega. At least with the money sorted now, I reckon that this will move up in the coming weeks. You will be OK with your investment. | likitorma | |
22/5/2019 10:49 | Likitorma.. Dont worry i am used to being left out of things. That,s why i,m always found in the kitchen at parties. Joking aside they probably looked to institutional investors for investment capital. Hopefully this works out cheaper than extending the bank over draft .Inmo this is a good move to cover expenses until sales of CD4 start ( Hopefully ) and food intolerance goes on sale in China. | upomega | |
22/5/2019 10:14 | If a sale of allergy side was imminent then perhaps no raise would have been needed. It's an interesting time but has risk been reduced? GLA. | p1nkfish | |
22/5/2019 09:19 | How much time does 635K with an overdraft buy them ? That is the question | buywell2 | |
22/5/2019 09:08 | Sneller has become trapped imho. No alternative but to cough up. Harwood are a decent value shop so they must see something here but its pocket change to them. | p1nkfish | |
22/5/2019 09:06 | It's a shame it has come to this. The monies raised being for a final small push and not some grand ambition. Its limping along and what alternative but to break up? | p1nkfish | |
22/5/2019 08:35 | Although I am pretty miffed that this fund-raising is mutually exclusive to a few significant investors , it surely has to be a positive signal to the market ? Here's why - 1) Sneller and Oryx are taking 76% of the entire issue , meaning their shareholdings go from 20% to 21.3% and 11.1% to 11.95% respectively . 2) There have been rumours of a fund-raising since the solid trading update in mid-April when the shares were 13p , and the RSI last night was below 20 . 3) The announcement reads as though everything is for sale except CD4 ; note there is no mention of food intolerance or allergies , and they have reiterated their year old remark of releasing short-term shareholder value . 4) My guess is that directors are not allowed to subscribe for this issue under LSE close season rules ? | bomber13 | |
22/5/2019 08:19 | I await results to see how much of the Bank Overdraft Facility ODX have used. I would expect to see Director buying after the Closed period has ended as there seems to be no Director buying in the Placing which is disappointing, at these low levels.. | barrywhit | |
22/5/2019 08:17 | I take Sneller as protecting his capital as without this raise there are problems. Would have been happier to see Harwood > Sneller as that is more of a value and greed shop imho. It suggests pressure will be on to sell off parts or all imho. A return for the investors. | p1nkfish | |
22/5/2019 07:19 | Good to see the 2 large holders still confident in ODX..small dilution...now let’s see some progress... | barrywhit | |
22/5/2019 07:15 | Now that the raise is sorted, this can motor on. Shame shareholders like Upomega has not been given the opportunity to participate, despite his close to 2% holdings. Note no directors buying in the placing. | likitorma | |
22/5/2019 07:10 | There you have it, what a shambles, more dilution: | hyperboreus | |
21/5/2019 23:42 | Directors happy to take their 6 digits package while shareholders suffer. Need to get the major shareholders to do something. | likitorma | |
21/5/2019 07:19 | Hope this helps Arthur: | hyperboreus | |
20/5/2019 23:23 | The world functions in weird ways, Upo. | likitorma | |
20/5/2019 23:19 | Let us hope its a partial sale to release some cash likitorma. Otherwise I cant see how the majority of investors together with the bod would benefit by a entire sale of the company. | upomega | |
20/5/2019 23:05 | Upomega, disagree since earliest they have released finals is towards end of June. If I recall correctly, new regs allow 30days for closed period prior to results. These guys have been in closed period for much longer. Mark my words, a sale is coming. | likitorma | |
20/5/2019 22:46 | Probably just down to final results being published as per previous years. Also any non corrupt listed company would be carrying out the same procedure.More so than ever these days inmo | upomega | |
20/5/2019 21:56 | I think there is a sale coming soon; hence, why the directors' are in closed period for such an extended period of time. The larger shareholders have also become insiders to get a feel for consensus; hence why they are not buying. Mark my words. | likitorma | |
20/5/2019 21:12 | As far as I can see it has always been updated.I cant see any news that hasn't been on there for a while.I.e trade fares | upomega | |
20/5/2019 20:55 | They could do with updating the investors section and putting pdf's of the annual reports on there as well. | arthur_lame_stocks | |
20/5/2019 20:49 | Crikey the News & Events section has been updated for the first time in over 12 months, clearly they are taking notice of my posts! 😂 | hyperboreus | |
20/5/2019 19:37 | Hopefully we should see some positive news on the launch of advanced cd4 and maybe progress in China re food intolerance. As a positive the company is still recruiting. | upomega |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions